Roche subsidiary TIB Molbiol rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant, as they continue to offer new and accurate detection solutions Three new testing kits are among the first to specify the mutations of the recently discovered Omicron variant, and can help manage the evolving COVID-19 pandemic Use of... Read more
Includes robust dual-target SARS-CoV-2 detection and identification of 4 S-gene mutations Reliable detection and even tentative differentiation of Omicron variant expected Validated with the GenoXtract® and GenoXtract ® fleXT extraction system Validated with Bruker’s novel FluoroCycler® XT real-time PCR thermocycler NEHREN, Germany–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its established CE-IVD marked FluoroType®... Read more
Thermo Fisher Scientific and Color Health Launch K-12 ReadyCheckGo COVID-19 Testing Solution for Texas Schools WALTHAM, Mass., Dec. 2, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, and Color Health, a health technology company committed to advancing public health, have launched a significant expansion of the K-12 ReadyCheckGo COVID-19 testing solution in Texas.... Read more
Wednesday, December 1, 2021 — Leading Provider of Environmental, Health & Safety, and Air Quality Sensors — Berwyn, Pa., Dec. 1, 2021 – AMETEK, Inc. (NYSE: AME) today announced the acquisition of Alphasense, a leading provider of gas and particulate sensors for use in environmental, health and safety, and air quality applications. Alphasense designs and manufactures... Read more
Effective at the open of market trading today, the Company will begin trading as Azenta, Inc. (Nasdaq: AZTA) CHELMSFORD, Mass., Dec. 1, 2021 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) (“Azenta” or the “Company”) announced today that it has completed its previously announced corporate name change from “Brooks Automation, Inc.” to “Azenta, Inc.” In conjunction with the corporate name... Read more
TIB Molbiol excels in ultra-rapid assay development for emerging infectious disease, strongly demonstrated during the COVID-19 pandemic The acquisition enables Roche to further expand the portfolio of currently over 45 CE-IVD assays and more than 100 research use assays on Roche’s LightCycler PCR instruments TIB Molbiol will continue to focus on the research and development... Read more
MENLO PARK, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ:PACB), a leading provider of high-quality, long-read sequencing platforms, welcomes Jason Kang as Vice President and General Manager for the company’s Asia-Pacific region. Jason will be responsible for leading and developing PacBio’s commercial team in Asia-Pacific as the company continues to expand its reach in... Read more
New High Fidelity CRISPR Cas9 Protein Reduces Off-target Effects for More Precise Genome Editing Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications CARLSBAD, Calif., Nov. 30, 2021 /PRNewswire/ — For research applications requiring highly precise genome editing, including engineering CAR T cells and creating cellular models for disease discovery, the Invitrogen... Read more
Collaborations with SOPHiA GENETICS, The University of Cambridge and Optellum are intended expand access to the latest and most advanced technologies for cancer care Chicago, Nov 30 2021 — GE Healthcare announced collaborations with SOPHiA GENETICS, The University of Cambridge and Optellum as part of its vision to advance care, make precision health more accessible,... Read more